Biotechnology, Medical Health Aged Care 13/02/2024 10:13

Blood test to detect dementia: expert available for comment

Neuroscience Research Australia < 1 mins read

< 1 mins read

Professor Matthew Kiernan AM CEO at Neuroscience Research Australia is available to provide expert comment on the development of an early blood test to predict dementia, as reported by the Guardian today based on research published in nature aging.

Professor Kiernan AM is an expert in neurodegenerative diseases, particularly motor neuron disease (MND) and frontotemporal dementia (FTD). He is a clinician scientist based at NeuRA.

Contact details:

Contact Michelle Smith OR Beatrix Kates

Senior Communications & PR Officer

0452 140 477

michelle.smith@neura.edu.au

b.kates@neura.edu.au

Media

More from this category

Medical Health Aged Care
23/12/2024
22:11

BeiGene, Ltd.

BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference

SAN MATEO, Calif.–BUSINESS WIRE– BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne…

Contains:

Medical Health Aged Care
23/12/2024
12:57

Royal Australian College of GPs

RACGP: Look after your mental health this holiday season

The Royal Australian College of GPs (RACGP) has urged Australians to look after themselves and their loved ones this holiday season. College President, Dr Michael Wright, said that reaching out and helping others can make all the difference. “The holiday season can be a challenging time for many Australians,” he said. “Many of us can have family and relationship pressures, financial pressures may become more obvious, and isolation and loneliness can be at their worst this time of year too. So, during this festive season please try to look after yourself and the people in your life. It can be…

Biotechnology, Science
23/12/2024
09:00

Brandon Capital

CUREator + deploys $18.5 million in its first funding round

MELBOURNE, Australia — 23 December 2024 CUREator +, has announced that eight local startups developing innovations with the potential to save lives and improve wellbeing will receive grants totalling $18.5 million in its first funding round. CUREator+, delivered in partnership with Brandon BioCatalyst and ANDHealth, is a national program focused on accelerating the research translation and commercialisation of preclinical and clinical early-stage Australian medical research and medical innovations with commercial potential. These innovations include drugs (novel and repurposed), devices, diagnostics and digital technologies that address unmet needs. Enabling rapid assessment of the efficacy of cancer treatments AI-powered platform providing early…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.

Book a demo Explore our plans